Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-13

FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (BE Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the original application for Neostigmine methylsulfate from BE Pharmaceuticals Inc., authorizing a generic version of this drug for approved uses i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)